A nationwide genomic screening project for small cell lung cancer in Japan (LC-SCRUM-Japan).

被引：1
作者：
Murakami, Haruyasu
Umemura, Shigeki
Shinoda, Masahiro
Shingyoji, Masato
Ogawa, Yukari
Takeda, Koji
Nosaki, Kaname
Okamoto, Norio
Aono, Hiromi
Hara, Satoshi
Kuyama, Shoichi
Sato, Akiko
Kanaji, Nobuhiro
Okimoto, Tamio
Kataoka, Yuki
Matsumoto, Shingo
Udagawa, Hibiki
Yoh, Kiyotaka
Tsuchihara, Katsuya
Goto, Koichi
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.8518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8518
引用
收藏
页数：5
相关论文
共 50 条
[21]   Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS-mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan). [J].
Tamiya, Yutaro ;
Zenke, Yochitaka ;
Matsumoto, Shingo ;
Furuya, Naoki ;
Sakamoto, Tomohiro ;
Kato, Terufumi ;
Nishino, Kazumi ;
Shingyoji, Masato ;
Miyamoto, Shingo ;
Shirakawa, Chigusa ;
Toyozawa, Ryo ;
Ohashi, Kadoaki ;
Ikeda, Takaya ;
Nosaki, Kaname ;
Udagawa, Hibiki ;
Kirita, Keisuke ;
Yoh, Kiyotaka ;
Niho, Seiji ;
Goto, Koichi .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[22]   Development of a Nationwide Genomic Screening Project (SCRUM-Japan) for the Establishment of Cancer Precision Medicine [J].
Goto, Koichi .
ANNALS OF ONCOLOGY, 2017, 28 :19-19
[23]   The Lung Cancer Genomic Screening Project for Individualized Medicine in Japan (LC-SCRUM-Japan): Screening for RET and ROS1 fusions in advanced EGFR mutation-negative nonsquamous lung cancer and development of molecular targeted therapy. [J].
Yoh, Kiyotaka ;
Matsumoto, Shingo ;
Tsuchihara, Katsuya ;
Kohno, Takashi ;
Ishii, Genichiro ;
Tsuta, Koji ;
Nishio, Makoto ;
Yamamoto, Noboru ;
Murakami, Haruyasu ;
Satouchi, Miyako ;
Nogami, Naoyuki ;
Seto, Takashi ;
Umemura, Shigeki ;
Niho, Seiji ;
Ohmatsu, Hironobu ;
Ohe, Yuichiro ;
Yamanaka, Takeharu ;
Goto, Koichi .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[24]   Clinicopathological features of patients with ROS1-rearranged advanced non-small cell lung cancer: LC-SCRUM-Japan [J].
Sugiyama, E. ;
Matsumoto, S. ;
Yoh, K. ;
Ohe, Y. ;
Seto, T. ;
Murakami, H. ;
Iwama, E. ;
Sugawara, S. ;
Yamada, K. ;
Takeda, K. ;
Hosomi, Y. ;
Saeki, S. ;
Yokoyama, T. ;
Nishio, M. ;
Satouchi, M. ;
Tsuta, K. ;
Kohno, T. ;
Ishii, G. ;
Tsuchihara, K. ;
Goto, K. .
EUROPEAN JOURNAL OF CANCER, 2015, 51 :S610-S610
[25]   The Nationwide Cancer Genome Screening Project in Japan SCRUM-Japan GI-SCREEN [J].
Kawazoe, Akihito .
ANNALS OF ONCOLOGY, 2018, 29 :26-26
[26]   Nationwide driver mutation analysis in advanced EGFR mutation-negative non-squamous lung cancer: LC-SCRUM-Japan [J].
Yoh, Kiyotaka .
ANNALS OF ONCOLOGY, 2015, 26 :40-40
[27]   Clinical Outcome of Non-Small Cell Lung Cancer with EGFR/HER2 Exon 20 Insertions Identified in the LC-SCRUM-Japan [J].
Udagawa, H. ;
Matsumoto, S. ;
Ohe, Y. ;
Satouchi, M. ;
Furuya, N. ;
Kim, Y. H. ;
Seto, T. ;
Soejima, K. ;
Hayakawa, D. ;
Kato, T. ;
Miyamoto, S. ;
Ohashi, K. ;
Saeki, S. ;
Ohta, H. ;
Fujimoto, D. ;
Sekine, A. ;
Yoh, K. ;
Goto, K. .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S224-S224
[28]   Activity on the Nationwide Cancer Genome Screening Project for Gastrointestinal Cancer in Japan; SCRUM-Japan GI-SCREEN [J].
Yoshino, Takayuki .
ANNALS OF ONCOLOGY, 2017, 28
[29]   Phase II study of gedatolisib for small-cell lung cancer (SCLC) patients (pts) with genetic alterations in PI3K/AKT/mTOR pathway based on a large-scale nationwide genomic screening network in Japan (EAGLE-PAT/LC-SCRUM-Japan). [J].
Udagawa, Hibiki ;
Ikeda, Takaya ;
Umemura, Shigeki ;
Daga, Haruko ;
Toyozawa, Ryo ;
Harada, Daijiro ;
Sakakibara-Konishi, Jun ;
Morise, Masahiro ;
Yamamoto, Noboru ;
Takahashi, Toshiaki ;
Kato, Terufumi ;
Shingyoji, Masato ;
Ushio, Ryota ;
Hara, Satoshi ;
Takata, Saori ;
Nomura, Shogo ;
Matsumoto, Shingo ;
Niho, Seiji ;
Sato, Akihiro ;
Goto, Koichi .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[30]   Activity on Nationwide Cancer Genome Screening Project for Metastatic Colorectal Cancer in Japan; SCRUM-Japan GI-SCREEN [J].
Yoshino, Takayuki .
ANNALS OF ONCOLOGY, 2019, 30 :46-46
12345